Neoadjuvant Chemotherapy or Endocrine Therapy for Invasive Ductal Carcinoma of the Breast With High Hormone Receptor Positivity and Human Epidermal Growth Factor Receptor 2 Negativity

Jiaqiang Zhang(Zhengzhou University), Szu‐Yuan Wu(Asia University)

JAMA Network Open

March 12, 2021

10.1001/jamanetworkopen.2021.1785

Cited by 63

Related Papers

Brown Seaweed Fucoidan Inhibits Cancer Progression by Dual Regulation of mir-29c/ADAM12 and miR-17-5p/PTEN Axes in Human Breast Cancer Cells

|Journal of Cancer|2016|69

Comparison of Acute and Chronic Surgical Complications Following Robot-Assisted, Laparoscopic, and Traditional Open Radical Prostatectomy Among Men in Taiwan

|JAMA Network Open|2021|69

Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity‐modulated radiation therapy techniques

|Cancer|2017|68

Association between long-term opioid use and cancer risk in patients with chronic pain: a propensity score-matched cohort study

|British Journal of Anaesthesia|2022|57

Penfluridol triggers cytoprotective autophagy and cellular apoptosis through ROS induction and activation of the PP2A-modulated MAPK pathway in acute myeloid leukemia with different FLT3 statuses

|Journal of Biomedical Science|2019|50